ペンシルベニアにおける悪性黒色腫の臨床試験
ペンシルベニア内の拠点で、悪性黒色腫に関する47件の研究が参加者を募集しています。
ペンシルベニア内の都市
公式研究テキスト（英語）
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Geisinger Medical Center, Danville
- 他7件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Thomas Jefferson University Hospital, Philadelphia
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05136196A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- St. Luke's University Health Network, Easton
- Penn State Health Milton South Hershey Medical Center, Hershey
- Fox Chase Cancer Center, Philadelphia
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06246916Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- Allegheny Health Network, Pittsburgh
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT05727904A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
- Children's Hospital of Philadelphia, Philadelphia
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
被験者募集中第2相
25歳以下 · 全性別 · 2026/09/24更新 · NCT07621614Pan-tumor MRD Study
- Lancaster General Hospital (UPenn), Lancaster
- Guthrie Foundation, Sayre
- Cancer Care Associates of York (CCAY), York
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/24更新 · NCT06605404Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Christiana Care Health System-Concord Health Center, Chadds Ford
- Fox Chase Cancer Center - East Norriton Hospital Outpatient Center, East Norriton
- UPMC Hillman Cancer Center Erie, Erie
- 他4件
被験者募集中第3相
75歳以上 · 全性別 · 2026/09/24更新 · NCT07068074BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- University of Pennsylvania, Philadelphia
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT04752826A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT04511013ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of Pennsylvania, Philadelphia
- WellSpan Medical Oncology & Hematology at York Cancer Center, York
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- University of Pittsburgh Medical Center, Pittsburgh
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/02更新 · NCT07070232Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/31更新 · NCT05896839Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital of Philadelphia, Philadelphia
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119Project: Every Child for Younger Patients With Cancer
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Geisinger Medical Center, Danville
- Penn State Children's Hospital, Hershey
- 他4件
被験者募集中観察研究
25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Research Site, Pittsburgh
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/19更新 · NCT07115043Investigating Real-Time Immunotherapy Symptoms Study
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中
18歳以上 · 全性別 · 2026/08/04更新 · NCT07280715Tebentafusp-tebn With LDT in Metastatic UM
- Thomas Jefferson University, Philadelphia
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/21更新 · NCT06626516Safety and Efficacy of OBX-115 in Advanced Solid Tumors
- Allegheny Research Institute (Melanoma/NSCLC), Pittsburgh
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/16更新 · NCT06060613Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/23更新 · NCT04114136A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中第1/2相
18歳〜70歳 · 全性別 · 2026/06/11更新 · NCT05361174Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中観察研究
18歳以上 · 全性別 · 2026/06/11更新 · NCT04658303Evaluation of Hypoxia in Primary Melanoma
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中観察研究
18歳以上 · 全性別 · 2026/06/10更新 · NCT06831071MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
- Fox Chase Cancer Center, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中第1/2相
18歳〜90歳 · 全性別 · 2026/06/10更新 · NCT05655312Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/08更新 · NCT03947385Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
- Fox Chase Cancer Center, Philadelphia
被験者募集中早期第1相
18歳以上 · 全性別 · 2026/05/22更新 · NCT05498792ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
- Thomas Jefferson University, Honickman Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- 他1件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/13更新 · NCT03686124Neoadjuvant Darovasertib in Primary Uveal Melanoma
- Jefferson Health Honickman Center, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/06更新 · NCT07015190A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/28更新 · NCT06413680A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
- UPenn, Philadelphia
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/04/22更新 · NCT06624644A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/20更新 · NCT06326411Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/16更新 · NCT07223424RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中早期第1相
18歳以上 · 全性別 · 2026/04/13更新 · NCT06216938A Study of VET3-TGI in Patients With Solid Tumors
- UPMC- Hillman Cancer Center, Pittsburgh
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/07更新 · NCT06444815A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Thomas Jefferson University, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中第2/3相
全年齢 · 全性別 · 2026/04/02更新 · NCT06581406Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- WellSpan Medical Oncology and Hematology, Chambersburg
- 他13件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
- Thomas Jefferson University Medical Oncology Clinic, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中第3相
18歳以上 · 全性別 · 2026/02/25更新 · NCT05549297Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
- St. Luke's University Health Network, Easton
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/13更新 · NCT04903119Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中観察研究
18歳以上 · 全性別 · 2026/01/26更新 · NCT06599619Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- Penn State Cancer Institute, Hershey
- Fox Chase Cancer Center 333 Cottman Avenue, Philadelphia
被験者募集中第3相
18歳以上 · 全性別 · 2025/12/17更新 · NCT03567889ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。